Sagent Pharmaceuticals, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Nothing new has been filed by managers of Sagent Pharmaceuticals, Inc. in twelve months, the latest record being from 1 September 2016.
The full history, which starts in 2016, counts no purchases against 4 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
25 of 81 declarations
Sagent Pharmaceuticals, Inc. is a company that specializes in the manufacturing and distribution of generic pharmaceutical products. It primarily operates in the U.S. market and focuses on injectable medications.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2015 | n.d. | -21.9 m USD | -0.67 USD | 10-K |
| Dec 2014 | n.d. | 37.0 m USD | 1.13 USD | 10-K |
| Dec 2013 | n.d. | 29.6 m USD | 0.99 USD | 10-K |
| Dec 2012 | n.d. | -16.8 m USD | -0.60 USD | 10-K |
| Dec 2011 | n.d. | -26.4 m USD | -1.31 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.